Ascites News and Research

RSS
BIDMC scientists develop new tool to benefit patients with HCV-associated liver failure

BIDMC scientists develop new tool to benefit patients with HCV-associated liver failure

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Study: One-third of bacterial infections in patients with cirrhosis induced by MDR bacteria

Study: One-third of bacterial infections in patients with cirrhosis induced by MDR bacteria

Using the Microbiome to Predict the Risk of Cirrhosis-Associated Hospitalization

Using the Microbiome to Predict the Risk of Cirrhosis-Associated Hospitalization

Novel oncolytic virus expressing BiTE molecule elicits T cell-mediated killing of tumor cells

Novel oncolytic virus expressing BiTE molecule elicits T cell-mediated killing of tumor cells

Drinking during late adolescence could be first step to liver problems in adulthood

Drinking during late adolescence could be first step to liver problems in adulthood

Researchers describe key cellular receptor involved in ovarian cancer metastasis

Researchers describe key cellular receptor involved in ovarian cancer metastasis

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Immune-boosting drug combination may hold promise for treating ovarian cancer

Immune-boosting drug combination may hold promise for treating ovarian cancer

Hospitals need to improve emergency care practices for treating older cancer patients, study reveals

Hospitals need to improve emergency care practices for treating older cancer patients, study reveals

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Portal vein hypertension diminishes after hepatitis C recovery

Portal vein hypertension diminishes after hepatitis C recovery

UCLA researchers find new way to reduce ascites with minimal side effects

UCLA researchers find new way to reduce ascites with minimal side effects

Replacing animal-derived antibodies with modern technologies can improve quality of research, reduce costs

Replacing animal-derived antibodies with modern technologies can improve quality of research, reduce costs

Unituxin (dinutuximab) granted EC Marketing Authorisation for treatment of childhood neuroblastoma

Unituxin (dinutuximab) granted EC Marketing Authorisation for treatment of childhood neuroblastoma

BRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical School

BRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical School

Novogen's Anisina granted FDA Orphan Drug Designation for neuroblastoma

Novogen's Anisina granted FDA Orphan Drug Designation for neuroblastoma

Study shows that Anisina has potential to improve effectiveness of chemotherapy in children with cancer

Study shows that Anisina has potential to improve effectiveness of chemotherapy in children with cancer

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment